Avalo Therapeutics Inc (FRA:C6K0)
€ 8.76 -0.04 (-0.45%) Market Cap: 10.15 Mil Enterprise Value: -73.04 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript

Oct 19, 2021 / 12:00PM GMT
Release Date Price: €5328 (-4.15%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot